Lorven Biologics develops and manufactures high-purity bio-pharmaceuticals, APIs, and in-vitro diagnostic kits. They leverage microbial engineering and green chemistry to create accessible and cost-effective healthcare solutions, also offering contract research services for strain engineering and fermentation optimization.
Funding
Funding not disclosed
Founders
Product
Problem
The development and manufacturing of complex biologics, APIs, and diagnostic tools face challenges related to accessibility, affordability, and sustainable production processes. Traditional methods can be costly, time-consuming, and may not meet evolving global regulatory standards.
Solution
Lorven Biologics provides a comprehensive suite of biotechnology solutions, encompassing bio-pharmaceuticals, synthetic chemistry for APIs and intermediates, and in-vitro diagnostic kits. Leveraging advanced microbial engineering, synthetic biology, and green chemistry principles, the company develops high-purity products with optimized yields and reduced environmental impact. Their offerings aim to make advanced healthcare solutions more accessible and cost-effective. Lorven Biologics also offers contract research services, including strain engineering and fermentation optimization, to support client-specific development needs.
Target Audience
The primary customers are pharmaceutical companies, biotechnology firms, diagnostic laboratories, food safety organizations, and academic research institutions seeking high-quality biological products, APIs, diagnostic tools, and specialized R&D services.
Features
- **Bio-Pharmaceuticals:** Development and production of APIs including GLP-1 receptor agonists (Liraglutide, Semaglutide), Parathyroid Hormone (PTH), Recombinant Human Albumin, Ranibizumab, Human Growth Hormone, L-Asparaginase, and PEG-Asparaginase.
- **Synthetic Chemistry:** Manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates such as Tapentadol-HCl, Sitagliptin-Phosphate, Phenylephrine-HCl, Apixaban, Pregabalin, and a portfolio of over 100 pyridine derivatives.
- **In-Vitro Diagnostics (IVD):** A range of diagnostic kits for detecting antibiotic residues, mycotoxins, COVID-19 antigens and antibodies, Malaria, Brucellosis, Foot-and-Mouth Disease (FMD), Dengue, Chikungunya, HIV, Hepatitis B and C, Typhoid, Filariasis, and pregnancy. Also includes Viral Transport Medium (VTM).
- **Enzymes & Biocatalysis:** Development of specialized enzyme libraries (Keto-Reductase, Transaminase, Esterase) for green chemistry applications in API synthesis and biocatalysis.
- **Probiotics & Prebiotics:** Formulations including Saccharomyces Boulardii, Bacillus clausii spores, Lactic Acid Bacillus, synbiotics (probiotics + prebiotics), and probiotic-mineral combinations.
- **Research & Development Platforms:** Expertise in bacterial and yeast expression systems, mammalian cell culture, synthetic biology, and metabolic engineering for scalable bioprocess development.
- **Quality & Compliance:** Manufacturing adheres to cGMP guidelines, with products tested for purity, identity, endotoxins, and sterility, and documentation available for regulatory submissions (CDSCO, EMA, ICH).
- **Contract Research Services:** Offerings include custom microbial strain engineering, fermentation process optimization, tailored enzyme research, and diagnostic kit development.